Diabetes medicines spend rises by almost 20% in one year NHS Business Services Authority data have also revealed that almost 1 million patients received diabetes medicines in the most deprived areas of England in 2024/2025.…
Pharmacists reduce wait for mental health medication reviews by average of five weeks Speaking at the Royal Pharmaceutical Society Scotland Conference, Michael Mitchell said that NHS Lanarkshire placed pharmacists into its child and adolescent mental health services to “increase prescribing capacity, reduce wait times and make a difference”.…
Best practice for consultations with patients with additional speech and hearing needs Hearing loss and speech difficulties can make effective communication with patients more challenging. There are several ways pharmacists can tailor their consultations to optimise communication.…
Government and APBI fail to reach agreement on cost of branded medicines The levy paid to the government on the sales of branded medicines to the NHS is higher than the rates paid in other countries, such as Ireland, Belgium, Germany and France.…
Health news round-up: NICE approvals, fighting AMR and medicines safety concerns Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
First home-based digital technologies approved for cardiac rehabilitation The National Institute for Health and Care Excellence said digital technologies could offset the low uptake of traditional cardiac rehabilitation programmes.…
Facilitated self‑selection of P medicines: absent evidence, present riskAs a long-standing member and Fellow of the Royal Pharmaceutical Society (RPS), I was concerned to read that the RPS has reversed its position on the open display of Pharmacy (P) medicines. The RPS justifies this major policy shift primarily based on a literature review published as a non-peer-re…
NHS home testing identifies hundreds with hepatitis C More than 105,000 people in England have ordered the test since the home-testing service launched in May 2023, with more than 200 testing positive.…
Major step forward as bladder cancer treatment approved in England The National Institute for Health and Care Excellence estimates that more than 1,200 people each year in England could benefit from the enfortumab vedotin and pembrolizumab combination therapy.…
Designed by AI: the future of antibody drugs Artificial intelligence is enabling the next generation of antibody drugs — and helping to ‘drug the undruggable’. Meet the start-ups that are designing these treatments from scratch.…
